Press Release

PhRMA Supports Military Reservists and Disaster Workers

PhRMA April 24, 2013

Washington, D.C. (February 17, 2011) — The Pharmaceutical Research and Manufacturers of America (PhRMA) and Del Persinger, senior vice president and CFO, have been honored by Employer Support of the Guard and Reserve (ESGR) for PhRMA’s ongoing support and encouragement of employees serving in military reserve and federal disaster support systems. Mr. Persinger and PhRMA were cited in particular for PhRMA’s support of Dr. Erin Mullen, R.Ph., Ph.D., during her deployments with the National Disaster Medical System, and Dr. Paul Antony, M.D., M.P.H., during his combat deployments with the United States Navy Reserve.

“We are so proud of Del Persinger and Doctors Antony and Mullen” said PhRMA President and CEO, John J. Castellani. “Del’s longstanding support for our employees and for their continuing service to our country inspires us all as does Dr. Mullen’s work with the National Disaster Medical System providing earthquake relief in Haiti and Dr. Antony’s combat service in Iraq and Afghanistan.”

“PhRMA is strongly committed to doing everything we can to support our employees when they are called upon to fulfill their military reserve duties or volunteering to lend their special skills to national disaster relief efforts,” said Mr. Persinger. “Doctors Mullen and Antony embody the spirit of dedication to public service and humanity, and we are privileged to do all we can to help them.”

Dr. Antony is PhRMA’s Chief Medical Officer and Dr. Mullen is PhRMA Assistant Vice President for Finance and Operations and Director of Rx Response (

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $45.8 billion in 2009 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.3 billion in 2009.

PhRMA Internet Address:
For information on how innovative medicines save lives, visit:
For information on the Partnership for Prescription Assistance, visit:
For more information on public health emergencies, visit
For information on the danger of imported drugs, visit: